Weight Loss FDA Approved Approved

Liraglutide

Saxenda / Victoza

First GLP-1 agonist approved for chronic weight management, with ~8% loss in trial averages.

Quick Facts

Amino Acids 31
Route subcutaneous
Evidence FDA Approved
FDA Status Approved

Mechanism of Action

GLP-1 receptor agonist -- earlier generation, daily injection